Breakthrough Phase 2 Trial Results Show Promise for Patients Ineligible for Standard Reperfusion TherapiesData Presented at International Stroke ConferenceData Show That LT3001 Delivers Meaningful ...
Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...
7hon MSN
Three-way quantum correlations fade exponentially with distance at any temperature, study shows
The properties of a quantum material are driven by links between its electrons known as quantum correlations. A RIKEN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results